Russo Partners

How do biotech stories make it from lab to headline? @Solomonswisdom talks with @h_m_mac of @BioSpace & @BenGlickman of @WSJ on what earns trust, builds clarity & gets your story noticed. 🎙️ Listen now: bit.ly/3LdxVpf 🎧 Apple Podcasts: apple.co/436HpbZ 🎥 YouTube: bit.ly/4oOjF4X #Biotech #MediaRelations #LifeSciences

Longevity is becoming a major investment opportunity. From full-body scans to AI-driven diagnostics and personalized genomics, longevity is evolving into a scalable, data driven market. Great coverage by the @latimes on why LA is emerging as a hub for this shift. lat.ms/4dQCDFB #Longevity #HealthTech #FutureOfHealthcare

Health systems aren’t creating separate budgets for AI, instead, it’s being embedded into enterprise IT and evaluated alongside other core technology investments. Read about this shift in @BeckersHR by @NaomiCDiaz: bit.ly/4sHVpDL #HealthcareAI #DigitalHealth

Public health isn’t just a policy issue; it’s a trust issue. Tony Russo, Ph.D., of @RussoPartners, shares insights from our Board of Advisors meeting on the erosion of public health institutions and their impact on patient and biotech outcomes. bit.ly/3PEaRlQ #PublicHealth #Biotech #HealthPolicy #Healthcare

In @PharmaVoice, Omar Khalil of Santé Ventures points to improving public markets, capital deployment returning, and more realistic valuations as drivers of renewed momentum across biotech. bit.ly/4t8Vd0l #Biotech #VentureCapital #LifeSciences

Biotech doesn’t just save lives; it also drives jobs and economic growth. In @statnews, John F. Crowley of @IAmBiotech, reflects on biotech’s 50th anniversary and what comes next, including the need to address intermediaries that can increase costs and limit patient access. While recent policy steps are a start, more must follow. bit.ly/4t70mpG #Biotech #HealthcarePolicy #Innovation

Great to see @SDbizjournal coverage by @walsh_eli on @LabtoLeader’s acquisition of 2Connect Presentation & Communication Training, highlighting Gaylene Xanthopoulos and the focus on leadership and communication skills for life sciences executives. bit.ly/4dDFh1i #Biotech #Leadership #LifeSciences

Registration is open for the 2026 @abfoCFOs National Conference, May 26–29, in Philadelphia, PA, convening biotech CFOs & finance leaders for keynotes, breakouts, and 16+ CPE credits available. Register now: bit.ly/4r88XXv #FinanceFunction #BiotechFinance

20M people worldwide live with spinal cord injury, with ~$5M in lifetime costs per patient. On the Russo Edge Podcast, @SolomonsWisdom speaks with Adrien Cohen of SCI Ventures about the scale of the challenge and why innovation targeting the nervous system could also impact ALS, MS, stroke, and brain injury. Listen now: bit.ly/4s8080L 🎧 Apple Podcasts: apple.co/47bHpcy 🎥 YouTube: bit.ly/4rEfmuR #SpinalCordInjury #Neuroscience #ALS #MultipleSclerosis #Stroke #Podcast

Is private equity investing in healthcare an issue? No. According to @Forbes contributor @EconTony at @UWMadison, competition may be the bigger factor at play. Analysis of the dental sector by @AmerDentalAssn explains how market dynamics, and not investment from private equity can influence pricing and care patterns. Read more: bit.ly/4doD2yT #Healthcare #HealthPolicy #Competition #PrivateEquity

@TechnologyMagBC recently highlighted @PwC’s healthcare M&A outlook report showing how AI-driven drug discovery, virtual care and ambient clinical documentation are transforming healthcare operations and investment priorities. Read more: bit.ly/40v2oDD #AIinHealthcare #DigitalHealth

Our work at the Super Bowl highlights how @RussoPartners’ Sports-Health Alliance, led by @SolomonsWisdom with @DavidSchull, is keeping a full schedule of projects with emerging healthcare companies, connecting sports, health, and media to expand visibility. #SportsHealth #HealthcareInnovation #HealthCommunications #EmergingCompanies

Venture philanthropy blends VC discipline with a mission, and it’s still relatively underused in parts of Europe. In this Russo Edge clip, hear from Adrien Cohen of SCI Ventures on what makes it unique. 🎙️Listen now: bit.ly/4s8080L 🎧 Apple Podcasts: apple.co/47bHpcy 🎥 YouTube: bit.ly/4rEfmuR #SpinalCordInjury #VenturePhilanthropy #ImpactInvesting #LifeSciences #HealthInnovation

AI momentum is growing in life sciences. 48% of executives cite accelerated digital transformation, up from 36% in 2025. Turning investment into tangible results is still a work in progress. Read the full analysis from @Deloitte: bit.ly/4ldAW6Z #LifeSciences #AI #Biotech #DigitalHealth

A @BioBuzzNetworks post-conference wrap-up highlights Maryland’s thriving biotech research strength, manufacturing infrastructure, and collaborative network that is fueling its growth. bit.ly/4rDTD6f #Biotech #LifeSciences #Maryland #Innovation

Startup grit, mission focus, and a new model to accelerate #SCI therapies. On the latest Russo Edge Podcast, host @SolomonsWisdom talks with Adrien Cohen of SCI Ventures on the push to accelerate treatments for spinal cord injury and paralysis via a venture philanthropy model. 🎙️Listen now: bit.ly/4s8080L 🎧 Apple Podcasts: apple.co/47bHpcy 🎥 YouTube: bit.ly/4rEfmuR #VenturePhilanthropy #SpinalCordInjury #Paralysis #ImpactInvesting #Podcast

Digital health may be stabilizing in 2026, but competition is fierce. Companies that win will focus on differentiation, integration, profitability, and measurable outcomes as AI reshapes the market. bit.ly/4rLcHPK #DigitalHealth #HealthTech #VirtualCare

As private equity reshapes healthcare marketing, clarity matters. In an @MMMnews op-ed, Tom Donnelly of Supreme Group examines what effective, long-term partnerships with private equity firms should look like. bit.ly/4u0RAuD #HealthcareMarketing #PrivateEquity #HealthTech

Health Tech M&A is picking up as AI capability gaps make buying faster than building, and the pressure to scale is pushing buyers and sellers to move. Read more from reporter @nyeungs at @endpts: bit.ly/4abExhV #HealthTech #DigitalHealth #MandA #HealthcareInnovation

What biotech problems are you really solving? Why now? Why your team? On the Russo Edge, @SahirAli of @ModiVentures shares what biotech investors look for early: a clear problem, a real reason the timing works, and a team that can execute. 🎙️Listen now: bit.ly/4aaJF5Y 🎧 Apple Podcasts: bit.ly/4twmOcA 🎥 YouTube: bit.ly/4tudsOr #Leadership #Biotech #LifeSciences #StartupLeadership #FounderJourney #ScientificLeadership #VentureCapital

In @HealthLeaders, @eriwick shares from Barry Stein, MD, MBA of Hartford HealthCare and his five predictions for #HealthcareAI in 2026. Barry points to AI making care more human, becoming a true clinical partner, and a growing focus on trust, transparency, and governance. bit.ly/4bOdwm3 #DigitalHealth #HealthTech #Innovation